期刊文献+

不同剂量依达拉奉对大鼠心肌缺血再灌注损伤保护作用的研究 被引量:1

下载PDF
导出
作者 张弛 郑李娜
机构地区 山西医科大学
出处 《山西医药杂志(上半月)》 CAS 2010年第10期929-930,共2页 Shanxi Medical Journal
  • 相关文献

参考文献7

  • 1Satoh K,Ikeda Y,Shioda S,et al.Edarbone scavenges nitric oxide.Redox Rep,2002,7(4):219-222.
  • 2Hayashi T,Mori T,Sohmiya K,et al.Efficacy of edaravone,a free radical scavenger,on left ventricular function and structure in diabetesmellitus.J Cardiovasc Pharmacol,2003,41 (6):923-929.
  • 3周庆玲,吴建文,方玉松,焦齐,肖伟.依达拉奉对肺缺血再灌注损伤保护作用的实验研究[J].山东大学学报(医学版),2007,45(2):130-134. 被引量:26
  • 4Hiranuma S,Ito K,Noda Y,et al.Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats.J Gastroenterol Hepatol,2007,22 (12):2167-2172.
  • 5Matsuyama M,Hayama T,Funao K,et al.Treatment with edaravone improves the survival rate in renal warm ischemia-reperfusion injury using rat model.Transplant Proc,2006,38 (7):2199-2200.
  • 6Tomatsuri N,Yoshida N,Takaqi T,et al.Edaravone,a newly developed radical scavenger,protects against ischemia-reperfusion injury of the small intestine in rats.Int J Mol Med,2004,13(1):105-109.
  • 7段永壮,王增涛,钟世镇,丁自海,付庆林,郝丽文,何波,缪博.依达拉奉对断肢再植后缺血再灌注损伤大鼠骨骼肌线粒体的保护作用及机制[J].山东医药,2007,47(9):15-17. 被引量:7

二级参考文献19

  • 1夏舒萌,张德琛,吴小晶,于卫江,史辛波,陈立芳,郑戈.线粒体功能与骨骼肌缺血再灌注损伤的关系[J].中国临床康复,2005,9(2):103-105. 被引量:8
  • 2Alam S,Chan KM.Noninfectious pulmonary complications after organ transplantation[J].Curr Opin Pulm Med,1996,2(5):412-418.
  • 3Sekido N,Mukaida A,Harada A,et al.Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8[J].Nature,1993,365 (6447):654-657.
  • 4Cakir O,Oruc A,Kaya S,et al.N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest[J].J Card Surg,2004,19(3):221-225.
  • 5Zheng JH,Xu ZW,Wang W,et al.Lung perfusion with oxygenated blood during aortic clamping prevents lung injury[J].Asian Cardiovasc Thorac Ann,2004,12(1):58-60.
  • 6Abe T,Unno M,Takeuchi H,et al.A new free radical scavenger,edaravone,meliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo[J].J Gastrointest Surg,2004,8(5):604-615.
  • 7Tomatsuri N,Yoshida N,Takagi T,et al.Edaravone,a newly developed radical scavenger,protects against ischemiareperfusion injury of the small intestine in rats[J].Int J Mol Med,2004,13(1):105-109.
  • 8Yamawaki M,Sasaki N,Shimoyama M,et al.Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes[J].Br J Pharmacol,2004,142(3):618-626.
  • 9Doi K,Suzuki Y,Nakao A,et al.Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney[J].Kidney Int,2004,65(5):1714-1 723.
  • 10Irie H,Kato T,Ikebe K,et al.Antioxidant effect of MCI-186,a new Free-Radical scavenger,on ischemia-reperfusion injury in a rat hindlimb amputation model[J].J Surg Res,2004,120(2):312-319.

共引文献29

同被引文献22

  • 1Sukmawan R, Yada T, Toyota E, et al. Edaravone pre- serves coronary microvascular endothelial function after ischemia/reperfusion on the beating canine heart in vivo [J]. J Pharmacol Sci, 2007,104 (4) : 341-348.
  • 2Yamazaki K, Miwa S, Toyokuni S, et al. Effect of edara- vone,a novel free radical scavenger, supplemented to car- dioplegia on myocardial function after cardioplegic arrest. in vitro study of isolated rat heart[J]. Heart Vessels, 2009,24(3) :228-235.
  • 3Onogi H, Minatoguchi S, Chen XH, et al. Edaravone re- duces myocardial infarct size and improves cardiac func- tion and remodelling in rabbits [J]. Clin Exp Pharmacol Physiol, 2006,33 ( 11 ) : 1035-1041.
  • 4Shimazaki H, Watanabe K, Veeraveedu PT, et al. The an- tioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myo-carditis[J]. Free Radic Res, 2010,44(9) : 1082-1090.
  • 5Ishizawa M, Mizushige K, Noma T, et al. An antioxidant treatment potentially protects myocardial energy metabo- lism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model [J]. Life Sci, 2006,78 (25) : 2974-2982.
  • 6Yano M,Okuda S,Oda T,et al. Correction of defective in- terdomain interaction within ryanodine receptor by an- tioxidant is a new therapeutic strategy against heart fail- ure[J]. Circulation, 2005,112(23) . 3633-3643.
  • 7Tsujita K, Shimomura H ,Kaikita K,et al. Long-term effi- cacy of edaravone in patients with acute myocardial in- farction[J]. Circ J, 2006,70 (7) : 832-837.
  • 8李颖庆,符晖,文红艳.依达拉奉对扩张型心肌病的临床疗效观察[J].中国心血管病研究,2008,6(9):664-666. 被引量:3
  • 9李颖庆,谭小进,符晖,文红艳.依达拉奉治疗病毒性心肌炎疗效观察[J].现代医药卫生,2009,25(1):5-7. 被引量:1
  • 10刘振吉,李永强,赵树芬.依达拉奉对急性心肌梗死静脉溶栓治疗再灌注损伤的影响[J].现代中西医结合杂志,2009,18(8):889-890. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部